A Follow-up Study to Assess Long-term Immunogenicity and Safety of NicVAX/Placebo as an Aid to Smoking Cessation

NCT01304810 · clinicaltrials.gov ↗

COMPLETED

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Smoking Cessation
Nicotine Dependence

Interventions

BIOLOGICAL: NicVAX vaccine
BIOLOGICAL: Placebo

Sponsor

Nabi Biopharmaceuticals